ISRZF:OTC-iShares II Public Limited Company - iShares $ High Yield Corporate Bond UCITS ETF (USD)

ETF | Others |

Last Closing

USD 93.82

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

N/A

USD 32.85B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
EBCRY EBCRY

N/A

USD 3.26B
SSEEF SSgA SPDR ETFs Europe I Public..

N/A

USD 2.95B
IFXAF iShares Asia Trust - iShares F..

N/A

USD 2.94B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B
ISRPF iShares Public Limited Company..

N/A

USD 2.22B

ETFs Containing ISRZF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.80% 17% F 54% F
Dividend Return 3.18% 67% D+ 54% F
Total Return 3.99% 32% F 56% F
Trailing 12 Months  
Capital Gain 2.71% 21% F 58% F
Dividend Return 6.21% 94% A 73% C
Total Return 8.92% 35% F 62% D
Trailing 5 Years  
Capital Gain -9.75% 21% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.75% 20% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain -1.66% N/A N/A 35% F
Dividend Return -0.18% N/A N/A 34% F
Total Return 1.48% N/A N/A 30% F
Risk Return Profile  
Volatility (Standard Deviation) 7.78% N/A N/A 98% N/A
Risk Adjusted Return -2.34% N/A N/A 33% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike